Healthy subjects | T2DM patients
Item
healthy subjects and t2dm patients
boolean
C1708335 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
African american | caucasian
Item
african american and caucasian
boolean
C0085756 (UMLS CUI [1])
C0043157 (UMLS CUI [2])
T2DM pharmaceutical preparations prescribed | metformin
Item
t2dm patients on controlled medication (taking metformin)
boolean
C0011860 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0278329 (UMLS CUI [1,3])
C0025598 (UMLS CUI [2,1])
C0278329 (UMLS CUI [2,2])
Dietary supplement before blood specimen collection
Item
dietary supplement within 2 weeks of enrollment
boolean
C0242295 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,3])
Recent fish oil supplements | plant oil supplements
Item
fish and plant oil supplements 2 months prior to enrollment
boolean
C0016157 (UMLS CUI [1,1])
C0242295 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0032085 (UMLS CUI [2,1])
C0242295 (UMLS CUI [2,2])
C0332185 (UMLS CUI [2,3])
Recent nsaids | aspirin
Item
nsaids and aspirin 1 week prior to enrollment
boolean
C0003211 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0004057 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
Smoking history
Item
smoking
boolean
C1519384 (UMLS CUI [1])
Recent cardiovascular event
Item
cardiovascular event within 6 months prior to enrollment
boolean
C1320716 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Other anti-platelet treatment | phosphodiesterase inhibitors | P2Y12R receptor antagonists
Item
other anti-platelet treatment including phosphodiesterase (pde) and p2y12r inhibitors
boolean
C0085826 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0031638 (UMLS CUI [2])
C2936585 (UMLS CUI [3])
Estimated GFR | severe renal insufficiency
Item
estimated glomerular filtration rate (egfr) below 30 (severe renal insufficiency)
boolean
C3811844 (UMLS CUI [1])
C1565489 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Estimated GFR
Item
egfr above 90
boolean
C3811844 (UMLS CUI [1])